<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xml:base="http://www.pharmaconnectme.com" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
 <title>PharmaConnectMe! - RSS Feed</title>
 <link>http://www.pharmaconnectme.com</link>
 <description></description>
 <language>en</language>
<item>
 <title>Viagra firm abandons EU action</title>
 <link>http://www.pharmaconnectme.com/newsroom/pharmaworld/viagra-firm-abandons-eu-action</link>
 <description>The makers of anti-impotence drug Viagra have withdrawn their bid to make it available without a prescription. Drug company Pfizer had wanted to make 50 milligram tablets freely available in the Europ&lt;p&gt;&lt;a href=&quot;http://www.pharmaconnectme.com/newsroom/pharmaworld/viagra-firm-abandons-eu-action&quot;&gt;more &amp;raquo;&lt;/a&gt;&lt;/p&gt;</description>
 <category domain="http://www.pharmaconnectme.com/pharmaworld">PharmaWorld</category>
 <comments>http://www.pharmaconnectme.com/newsroom/pharmaworld/viagra-firm-abandons-eu-action#comment</comments>
 <pubDate>Thu, 20 Nov 2008 22:42:28 +0100</pubDate>
 <dc:creator>admin</dc:creator>
 <guid isPermaLink="false">15295 at http://www.pharmaconnectme.com</guid>
</item>
<item>
 <title>Idera and Merck Extend R&amp;D Deal</title>
 <link>http://www.pharmaconnectme.com/newsroom/pharmaworld/idera-and-merck-extend-r-d-deal</link>
 <description>Idera Pharmaceuticals (NASDAQ:IDRA), a Cambridge, MA-based developer of drugs that target a family of immune system receptors, reports it has inked a one-year extension to its research collaboration w&lt;p&gt;&lt;a href=&quot;http://www.pharmaconnectme.com/newsroom/pharmaworld/idera-and-merck-extend-r-d-deal&quot;&gt;more &amp;raquo;&lt;/a&gt;&lt;/p&gt;</description>
 <category domain="http://www.pharmaconnectme.com/pharmaworld">PharmaWorld</category>
 <comments>http://www.pharmaconnectme.com/newsroom/pharmaworld/idera-and-merck-extend-r-d-deal#comment</comments>
 <pubDate>Thu, 20 Nov 2008 22:40:37 +0100</pubDate>
 <dc:creator>admin</dc:creator>
 <guid isPermaLink="false">15296 at http://www.pharmaconnectme.com</guid>
</item>
<item>
 <title>BRIEF-Jazz Pharmaceuticals and UCB announce positive phase III results</title>
 <link>http://www.pharmaconnectme.com/newsroom/pharmaworld/brief-jazz-pharmaceuticals-and-ucb-announce-positive-phase-iii-results</link>
 <description>The pricing, performance and/or news information provided above is only for your personal information and use and is not intended to address your particular requirements or to be relied upon in making&lt;p&gt;&lt;a href=&quot;http://www.pharmaconnectme.com/newsroom/pharmaworld/brief-jazz-pharmaceuticals-and-ucb-announce-positive-phase-iii-results&quot;&gt;more &amp;raquo;&lt;/a&gt;&lt;/p&gt;</description>
 <category domain="http://www.pharmaconnectme.com/pharmaworld">PharmaWorld</category>
 <comments>http://www.pharmaconnectme.com/newsroom/pharmaworld/brief-jazz-pharmaceuticals-and-ucb-announce-positive-phase-iii-results#comment</comments>
 <pubDate>Thu, 20 Nov 2008 22:38:08 +0100</pubDate>
 <dc:creator>admin</dc:creator>
 <guid isPermaLink="false">15297 at http://www.pharmaconnectme.com</guid>
</item>
<item>
 <title>Holzer Holzer &amp; Fistel, LLC Announces Investigation Into KV Pharmaceutical Company</title>
 <link>http://www.pharmaconnectme.com/newsroom/pharmaworld/holzer-holzer-fistel-llc-announces-investigation-into-kv-pharmaceutical-company</link>
 <description>ATLANTA, Nov. 20, 2008 (GLOBE NEWSWIRE) -- Holzer Holzer &amp; Fistel, LLC is investigating possible violations of the federal securities laws by KV Pharmaceutical Company (&#039;KV&#039; or the &#039;Company&#039;) (NYSE:KV-A) ..&lt;p&gt;&lt;a href=&quot;http://www.pharmaconnectme.com/newsroom/pharmaworld/holzer-holzer-fistel-llc-announces-investigation-into-kv-pharmaceutical-company&quot;&gt;more &amp;raquo;&lt;/a&gt;&lt;/p&gt;</description>
 <category domain="http://www.pharmaconnectme.com/pharmaworld">PharmaWorld</category>
 <comments>http://www.pharmaconnectme.com/newsroom/pharmaworld/holzer-holzer-fistel-llc-announces-investigation-into-kv-pharmaceutical-company#comment</comments>
 <pubDate>Thu, 20 Nov 2008 22:36:05 +0100</pubDate>
 <dc:creator>admin</dc:creator>
 <guid isPermaLink="false">15298 at http://www.pharmaconnectme.com</guid>
</item>
<item>
 <title>President-Elect Obama Likely To Pick CBO Director Orszag As Director Of U.S. Office Of Management And Budget</title>
 <link>http://www.pharmaconnectme.com/newsroom/pharmaworld/president-elect-obama-likely-to-pick-cbo-director-orszag-as-director-of-u-s-office-of-management-and-budget</link>
 <description>  President-elect Barack Obama reportedly plans to name Congressional Budget Office Director Peter Orszag as director of the White House Office of Management and Budget, the AP/Miami Herald reports (T&lt;p&gt;&lt;a href=&quot;http://www.pharmaconnectme.com/newsroom/pharmaworld/president-elect-obama-likely-to-pick-cbo-director-orszag-as-director-of-u-s-office-of-management-and-budget&quot;&gt;more &amp;raquo;&lt;/a&gt;&lt;/p&gt;</description>
 <category domain="http://www.pharmaconnectme.com/pharmaworld">PharmaWorld</category>
 <comments>http://www.pharmaconnectme.com/newsroom/pharmaworld/president-elect-obama-likely-to-pick-cbo-director-orszag-as-director-of-u-s-office-of-management-and-budget#comment</comments>
 <pubDate>Thu, 20 Nov 2008 21:00:00 +0100</pubDate>
 <dc:creator>admin</dc:creator>
 <guid isPermaLink="false">15299 at http://www.pharmaconnectme.com</guid>
</item>
<item>
 <title>Sen. Kennedy Taps Senators To Lead Various Working Groups Aimed At Improving U.S. Health Care</title>
 <link>http://www.pharmaconnectme.com/newsroom/pharmaworld/sen-kennedy-taps-senators-to-lead-various-working-groups-aimed-at-improving-u-s-health-care</link>
 <description>  Senate Health, Education, Labor and Pensions Committee Chair Edward Kennedy (D-Mass.) on Tuesday named committee members to lead three working groups that will target specific aspects of the health care ..&lt;p&gt;&lt;a href=&quot;http://www.pharmaconnectme.com/newsroom/pharmaworld/sen-kennedy-taps-senators-to-lead-various-working-groups-aimed-at-improving-u-s-health-care&quot;&gt;more &amp;raquo;&lt;/a&gt;&lt;/p&gt;</description>
 <category domain="http://www.pharmaconnectme.com/pharmaworld">PharmaWorld</category>
 <comments>http://www.pharmaconnectme.com/newsroom/pharmaworld/sen-kennedy-taps-senators-to-lead-various-working-groups-aimed-at-improving-u-s-health-care#comment</comments>
 <pubDate>Thu, 20 Nov 2008 19:00:00 +0100</pubDate>
 <dc:creator>admin</dc:creator>
 <guid isPermaLink="false">15300 at http://www.pharmaconnectme.com</guid>
</item>
<item>
 <title>Misconceptions Continue To Contribute To Discrimination Against HIV-Positive People In China, UNAIDS Official Says</title>
 <link>http://www.pharmaconnectme.com/newsroom/pharmaworld/misconceptions-continue-to-contribute-to-discrimination-against-hiv-positive-people-in-china-unaids-officia</link>
 <description>  People living with HIV/AIDS in China continue to experience discrimination based on public misconceptions of the disease, Bernhard Schwartlander, UNAIDS China country coordinator, said on Tuesday, X&lt;p&gt;&lt;a href=&quot;http://www.pharmaconnectme.com/newsroom/pharmaworld/misconceptions-continue-to-contribute-to-discrimination-against-hiv-positive-people-in-china-unaids-officia&quot;&gt;more &amp;raquo;&lt;/a&gt;&lt;/p&gt;</description>
 <category domain="http://www.pharmaconnectme.com/pharmaworld">PharmaWorld</category>
 <comments>http://www.pharmaconnectme.com/newsroom/pharmaworld/misconceptions-continue-to-contribute-to-discrimination-against-hiv-positive-people-in-china-unaids-officia#comment</comments>
 <pubDate>Thu, 20 Nov 2008 19:00:00 +0100</pubDate>
 <dc:creator>admin</dc:creator>
 <guid isPermaLink="false">15301 at http://www.pharmaconnectme.com</guid>
</item>
<item>
 <title>AstraZeneca &#039;buy,&#039; target price reduced</title>
 <link>http://www.pharmaconnectme.com/newsroom/pharmaworld/astrazeneca-buy-target-price-reduced</link>
 <description>8:38a.m. - Panmure Gordon &amp; Co LONDON, November 20 (newratings.com) - Analysts at Panmure Gordon reiterate their &#039;buy&#039; rating on AstraZeneca Plc (AZN-GBX). The target price has been reduced from 3315p&lt;p&gt;&lt;a href=&quot;http://www.pharmaconnectme.com/newsroom/pharmaworld/astrazeneca-buy-target-price-reduced&quot;&gt;more &amp;raquo;&lt;/a&gt;&lt;/p&gt;</description>
 <category domain="http://www.pharmaconnectme.com/pharmaworld">PharmaWorld</category>
 <comments>http://www.pharmaconnectme.com/newsroom/pharmaworld/astrazeneca-buy-target-price-reduced#comment</comments>
 <pubDate>Thu, 20 Nov 2008 18:10:56 +0100</pubDate>
 <dc:creator>admin</dc:creator>
 <guid isPermaLink="false">15288 at http://www.pharmaconnectme.com</guid>
</item>
<item>
 <title>AstraZeneca, Teva Patent Spat Flares Up</title>
 <link>http://www.pharmaconnectme.com/newsroom/pharmaworld/astrazeneca-teva-patent-spat-flares-up</link>
 <description> -- The stakes of a patent infringement suit between AstraZeneca PLC and Teva Pharmaceuticals Ltd.c.feeddirect.com&lt;p&gt;&lt;a href=&quot;http://www.pharmaconnectme.com/newsroom/pharmaworld/astrazeneca-teva-patent-spat-flares-up&quot;&gt;more &amp;raquo;&lt;/a&gt;&lt;/p&gt;</description>
 <category domain="http://www.pharmaconnectme.com/pharmaworld">PharmaWorld</category>
 <comments>http://www.pharmaconnectme.com/newsroom/pharmaworld/astrazeneca-teva-patent-spat-flares-up#comment</comments>
 <pubDate>Thu, 20 Nov 2008 18:09:23 +0100</pubDate>
 <dc:creator>admin</dc:creator>
 <guid isPermaLink="false">15289 at http://www.pharmaconnectme.com</guid>
</item>
<item>
 <title>Sanofi To Get $60M In Allegra Deal With Barr, Teva</title>
 <link>http://www.pharmaconnectme.com/newsroom/pharmaworld/sanofi-to-get-60m-in-allegra-deal-with-barr-teva</link>
 <description> -- Generic-drug makers Barr Pharmaceuticals Inc. and Teva Pharmaceuticals Industries Ltd. will pay Sanofi-Aventis $30 million each plus royalties to settle U.S. patent infringement litigation over ge&lt;p&gt;&lt;a href=&quot;http://www.pharmaconnectme.com/newsroom/pharmaworld/sanofi-to-get-60m-in-allegra-deal-with-barr-teva&quot;&gt;more &amp;raquo;&lt;/a&gt;&lt;/p&gt;</description>
 <category domain="http://www.pharmaconnectme.com/pharmaworld">PharmaWorld</category>
 <comments>http://www.pharmaconnectme.com/newsroom/pharmaworld/sanofi-to-get-60m-in-allegra-deal-with-barr-teva#comment</comments>
 <pubDate>Thu, 20 Nov 2008 18:08:46 +0100</pubDate>
 <dc:creator>admin</dc:creator>
 <guid isPermaLink="false">15290 at http://www.pharmaconnectme.com</guid>
</item>
</channel>
</rss>
